Last reviewed · How we verify
ENERGI-F703 GEL matched vehicle
ENERGI-F703 GEL matched vehicle is a Small molecule drug developed by Energenesis Biomedical Co., Ltd.. It is currently in Phase 3 development for Wound healing and tissue repair (specific indication under investigation in phase 3).
ENERGI-F703 is a topical gel formulation designed to promote wound healing and tissue repair through enhanced cellular regeneration.
ENERGI-F703 is a topical gel formulation designed to promote wound healing and tissue repair through enhanced cellular regeneration. Used for Wound healing and tissue repair (specific indication under investigation in phase 3).
At a glance
| Generic name | ENERGI-F703 GEL matched vehicle |
|---|---|
| Sponsor | Energenesis Biomedical Co., Ltd. |
| Modality | Small molecule |
| Therapeutic area | Dermatology/Wound Care |
| Phase | Phase 3 |
Mechanism of action
ENERGI-F703 GEL is a matched vehicle control formulation used in phase 3 clinical trials. As a vehicle control, it serves as the inactive comparator to evaluate the efficacy of the active drug formulation. The exact mechanism of the active component is proprietary to Energenesis Biomedical, but topical gels of this type typically work by promoting angiogenesis, collagen deposition, and epithelialization in wound healing applications.
Approved indications
- Wound healing and tissue repair (specific indication under investigation in phase 3)
Common side effects
Key clinical trials
- A Study to Evaluate ENERGI-F703 GEL in Diabetic Foot Ulcer (PHASE3)
- A Study to Evaluate ENERGI-F703 GEL in Venous Leg Ulcer (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- ENERGI-F703 GEL matched vehicle CI brief — competitive landscape report
- ENERGI-F703 GEL matched vehicle updates RSS · CI watch RSS
- Energenesis Biomedical Co., Ltd. portfolio CI
Frequently asked questions about ENERGI-F703 GEL matched vehicle
What is ENERGI-F703 GEL matched vehicle?
How does ENERGI-F703 GEL matched vehicle work?
What is ENERGI-F703 GEL matched vehicle used for?
Who makes ENERGI-F703 GEL matched vehicle?
What development phase is ENERGI-F703 GEL matched vehicle in?
Related
- Manufacturer: Energenesis Biomedical Co., Ltd. — full pipeline
- Therapeutic area: All drugs in Dermatology/Wound Care
- Indication: Drugs for Wound healing and tissue repair (specific indication under investigation in phase 3)
- Compare: ENERGI-F703 GEL matched vehicle vs similar drugs
- Pricing: ENERGI-F703 GEL matched vehicle cost, discount & access